Find Lawyers in America for Biotechnology and Life Sciences Practice
Select a location from the list below to find the best legal talent for your needs.
State
Biotechnology and Life Sciences Practice - America
About this Practice AreaAs co-chair of the firm's Life Sciences group, Bradford Addison has successfully prosecuted more than 10,000 original and complex patents over the course of his career. With a Ph.D. in pharmacology, Brad understands even the most cutting-edge science and technology behind innovation, as well as how to realize the true value of a commercially viable patent. Brad prepares and prosecutes patent applications in the chemical and biotech areas, including pharmaceuticals, molecular biology, instrume...
Over the course of more than 25 years as a patent attorney matched with in-house experience as a pharmaceutical chemist at DuPont Merck Pharmaceuticals and Smithkline Beecham, Allen Baum, partner-in-charge of the Raleigh office, has the ability to take complex scientific and legal issues and distill them into timely, relevant and useful counsel. Allen represents life sciences companies in patent and licensing matters. Clients hire Allen to identify and execute strategies to protect key commer...
Deborah Birnbach is a partner and co-chairs Goodwin’s Complex Litigation & Dispute Resolution and Public M&A / Corporate Governance practices and is a member of the firm’s Life Sciences Disputes group. She specializes in securities litigation, including class action defense; SEC, regulatory and internal investigations; M&A-related litigation; stockholder disputes; fiduciary duty claims; and proxy contests. Ms. Birnbach’s practice is national in scope and clients ...
Michael Bison is a partner in Goodwin’s nationally and internationally recognized Technology and Life Sciences practice group and a member of its Life Sciences and Capital Markets practices. He represents privately held and publicly traded companies with a strong emphasis on companies across the spectrum of the life sciences industry, including biotechnology, medical devices, diagnostics and healthcare information technology. Mr. Bison also regularly represents leading venture capital f...
Elaine Blais, head of the Litigation Department in Goodwin’s Boston office, focuses her practice on intellectual property litigation, particularly patent litigation, and she is a member of the firm’s Life Sciences Disputes group. Ms. Blais has first-chaired numerous lawsuits and taken cases to trial in federal courts nationwide. She serves on Goodwin’s Executive Committee and on its Intellectual Property Steering and Attorney Development Committees. Ms. Blais is the co-found...
Michael Brodowski is a patent lawyer and partner in the Boston office of Burns & Levinson LLP. Michael has two decades of experience counseling clients regarding the establishment and exploitation of patent rights in the United States and abroad to support clients’ business objectives including patent reexamination, reissue, and opposition proceedings. He also advises clients on avoiding the patent rights of others, and in connection with technology licenses and agreements, and pate...
Hall Bryant is a partner in the firm's Huntsville office. He concentrates his practice in the areas of mergers, acquisitions and divestitures, securities law, corporate finance and general corporate advice. Hall works with a variety of clients in a broad range of industries, including high technology, government contracting, biotechnology, manufacturing, retail, distribution and financial services. As a member of the firm's Emerging Business Team, Hall has worked with numerous early stage com...
With a background in chemical/biochemical engineering and nearly three decades of experience, pharmaceutical and biotechnology sector clients turn to John Burke for patent counsel. His work includes crafting an overall strategy aligning business with intellectual property, performing opinion work, negotiating license agreements, conducting due diligence, and prosecuting patent applications. John is continually ranked by leading industry publications including IAM Patent 1000 , which notes tha...
Mr. Calkins, a registered patent attorney, has over 20 years of experience in client counseling and portfolio management in patent procurement, licensing and enforcement, primarily in the life sciences, chemical, medical and computer software arts. His current practice also focuses on the corporate and transactional aspects of intellectual property, including licensing, merger, acquisition and/or equity investment due diligence. Mr. Calkins' experiences allow him to understand the business va...
Sarah is a Fellow in the American College of Trial Lawyers. Over the last dozen years, she has led 16 patent infringement, trade secrets and invalidity trials (ten jury trials, six bench trials) across several jurisdictions, including the federal courts in Massachusetts, Florida, Delaware, Colorado, California and Texas. Read full biography: https://www.mwe.com/people/columbia-sarah-chapin/
With deep knowledge of issues facing the life sciences industry, John Cox counsels clients regarding their worldwide intellectual property rights and represents their patent interests when litigation arises, particularly regarding pharmaceutical, chemical, and biotechnology matters. John takes his role in protecting these important assets of life science innovators very seriously while approaching each matter with enthusiasm. Through his ability to communicate effectively and succinctly, John...
Mandy Wilson Decker is a Patent Attorney and member of the Intellectual Property & Technology Service Group. Her practice focuses on intellectual property protection strategy, including counseling clients on infringement, validity and patentability, transfer of intellectual property, patent drafting, and patent prosecution. Contributing to her practice is a scientific background in chemistry and experience with academic and commercial research in the areas of biochemistry, biotechnology, ...
Chris Denn, a partner in Goodwin’s Life Sciences practice where he assists boards of directors and management teams in navigating the wide variety of commercial and legal issues that are critical to the success of a company’s efforts to deliver new treatments to patients. Mr. Denn has a comprehensive understanding of the life science industry informed by years spent as an in-house lawyer at AstraZeneca and extensive experience in private practice advising clients ranging from star...
Mr. Erwin focuses his practice on mergers and acquisitions, biotechnology and health care. Mr. Erwin's clients include both foreign and domestic businesses in the industrial and service sectors, as well as technology companies and health care providers. He regularly serves as counsel and legal advisor to corporations, other businesses and health care providers on a variety of issues, including: Stock and asset purchases and sales, mergers, acquisitions and similar transactions, Strategic join...
William (Bill) Gaede focuses his practice on intellectual property litigation in the life sciences and medical device industries. Bill serves as lead counsel for a wide range of companies and research institutes and has extensive experience in litigating life science technologies such as antibodies, proteins, small molecules and diagnostics. In addition to his jury trial experience, Bill has argued before the US Circuit Court of Appeals for the Federal Circuit. He further provides risk manage...
Ken advises clients in all areas of intellectual property law with an emphasis in patent matters, and infringement and validity evaluations in chemical, pharmaceutical, biotechnological and medical device arts. With a focus on intellectual property prosecution, counseling, licensing and litigation-related issues, Ken’s extensive experience includes matters involving worldwide portfolio management, diligence in licensing and acquisition, US interferences, US reissues, US reexaminations a...
Jim has focused his practice on the worldwide procurement, defense and enforcement of patents in the biotechnology, biopharmaceutical, pharmaceutical and chemical industries. He has counseled biotechnology and biopharmaceutical clients since 1978 and drafted, prosecuted and defended some of the basic patents in recombinant DNA technologies. He has extensive experience in United States and worldwide patent prosecution and patent enforcement and defense in all areas of biotechnology and biophar...
Steven Highlander’s practice focuses on portfolio management for universities, non-profits and small to mid-sized corporate clients. Preparation and filing of patent applications, as well as prosecution of these cases, makes up the bulk of his docket. He also has considerable opinion experience for patentability, validity, infringement and inventorship disputes. Dr. Highlander has also been involved in over 20 interference proceedings, including several garnering Federal Circuit review....
Fred Kelly works extensively with life sciences companies. While he is primarily a trial lawyer, he also counsels life sciences companies on the False Claims Act, claims and class actions under state consumer protection acts, trade secret and non-competition matters; the licensing and protection of confidential and proprietary information; and product advertising and promotion. What do you focus on? I have successfully litigated and tried nearly every kind of commercial and product-related di...
Ken Kohler's practice involves a broad range of corporate and capital markets work, including public offerings and private placements of equity and debt securities, mergers and acquisitions of public and private companies, and disclosure and reporting matters under the federal securities laws. Mr. Kohler also has extensive experience representing banks, REITs, mortgage bankers and others in corporate finance, structured finance and securitization transactions. He is experienced in cross-borde...
Shawna serves as outside patent counsel to pharmaceutical and biotechnology management teams and universities where she engages in the formulation and implementation of global patent strategies. In addition, she assists clients with intellectual property due diligence, partnering negotiations and trademark protection. She has co-authored publications in scientific journals and speaks to various audiences regarding patent law topics. Prior to her legal career, Shawna worked in pharmaceutical m...
BACKGROUND Becky’s technical background includes 15 years of research and study in biological sciences. She earned a B.S. in Cell Biology at Lanzhou University (China), an M.S. in Plant Physiology at the Institute of Botany, Chinese Academy of Sciences, and a Ph.D. in Molecular Biology at the University of Missouri-Columbia where she was awarded a Molecular Biology Fellowship. Becky also worked as a research scientist at the Institute of Oceanology, Chinese Academy of Sciences, and cond...
David A. Lipkin focuses his practice on mergers and acquisitions (M&A) and related securities law matters for companies in the technology and life sciences sectors. He represents both public and private acquirers and target companies, as well as special committees, in large, complex and sophisticated M&A transactions, including tender offers, negotiated mergers and other acquisition structures involving both strategic investors and private equity firms. Read full biography: https://ww...
Jim Lisbakken, a partner and former Co-Chair of the firm's Technology Transactions & Privacy practice, focuses on business transactions, licensing, and joint ventures and corporations specifically in the life sciences and technology industries. He has experience serving as outside general counsel to boards of directors of public and private companies, and has advised clients on numerous strategic alliances and technology agreements with Eli Lilly, GlaxoSmithKline, Serono, Johnson & Jo...
Samuel T. Lockner enjoys a robust intellectual property and patent practice, which includes litigation, monetization, protection, trade secrets, and more. Lockner often serves as lead counsel representing companies in the biotechnology, biomedical device, bio-agricultural, and other related industrial sectors, both as plaintiffs and defendants. Many of Lockner’s cases are patent disputes under the Hatch-Waxman Act. His experience also includes Inter Partes Review (“IPR”) and...
Scott Ludwig advises a broad range of clients on corporate and tax issues in corporate acquisitions and sales, including the negotiation, drafting and reviewing of acquisition and sale documents. He is experienced in advising companies in high technology, life sciences, biotechnology and traditional products and services, including start-up and established companies. Scott utilizes a team approach by working closely with each client's advisors. This team approach has, over the years, proven t...
Dr. Alice Martin advises on domestic and international patent prosecution and litigation opinions. She delivers legal acuity, scientific and intellectual prowess and prompt attention to those she serves. Alice is valued for providing clear answers to complicated questions and practical solutions for even the most difficult challenges. In addition to her patent law practice, Alice is a geneticist by training. Her immediate understanding of science and cutting-edge invention is further supporte...
Kim Martin is the managing partner of the Firm’s Huntsville office and a member of the Firm’s Board of Governors. She serves as the Co-Chair of the firm's Life Sciences Practice Group and focuses her practice on general litigation with an emphasis on medical device and pharmaceutical products liability litigation. She has represented multi-national pharmaceutical and medical device manufacturers in litigation across the country. Most recently, she has been a national team member f...
Biotechnology and Life Sciences Practice Definition
The commercial success of these companies often depends on their ability to protect their intellectual property rights, to develop and commercialize their products in conformity with FDA and other regulatory requirements, to successfully raise financing from all available sources in both good and bad economic conditions, and to partner with larger companies in the industry to help bring their innovative products to the market. As a result, life sciences companies require significant legal expertise in the fields of intellectual property, FDA regulations, marketing compliance, licensing and collaborations, venture capital financings, public offerings, mergers and acquisitions, and commercial agreements unique to the industry, such as biologic and pharmaceutical manufacturing, supply, distribution, and co-promotion agreements. Biotechnology lawyers must be experts in one or more of these fields and be able to work collaboratively with legal experts in related fields.
Our Methodology
Recognition by Best Lawyers is based entirely on peer review. Our methodology is designed to capture, as accurately as possible, the consensus opinion of leading lawyers about the professional abilities of their colleagues within the same geographical area and legal practice area.
The Process
Best Lawyers employs a sophisticated, conscientious, rational, and transparent survey process designed to elicit meaningful and substantive evaluations of the quality of legal services. Our belief has always been that the quality of a peer review survey is directly related to the quality of the voters.
In Brief
The Upcycle Conundrum
by Karen Kreider Gaunt
Laudable or litigious? What you need to know about potential copyright and trademark infringement when repurposing products.
Wage and Overtime Laws for Truck Drivers
by Greg Mansell
For truck drivers nationwide, underpayment and overtime violations are just the beginning of a long list of problems. Below we explore the wages you are entitled to but may not be receiving.
My Husband Didn’t Want to Stay Married…But He Didn’t Want a Divorce
by Jennifer Billock
Patience—and the law—prevails when an uncooperative partner avoids divorce proceedings.
Enhancing Consumer Safety Through Winning Jury Trials and Substantial Settlements
by Justin Smulison
Firm founder and lead trial lawyer James P. Frantz discusses how landmark victories in litigation and trial protect consumers.